Programmed Cell Death Ligand 1 Expression in Resected Lung Adenocarcinomas: Association with Immune Microenvironment
Tiffany G. Huynh(Massachusetts General Hospital), Mari Mino–Kenudson(Massachusetts General Hospital)
Cited by 88
Related Papers
<i>EGFR</i> Mutations and <i>ALK</i> Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective Analysis
|Clinical Cancer Research|2016|1.2k
A Novel, Highly Sensitive Antibody Allows for the Routine Detection of <i>ALK</i> -Rearranged Lung Adenocarcinomas by Standard Immunohistochemistry
|Clinical Cancer Research|2010|423
Surrogate Markers for Antiangiogenic Therapy and Dose-Limiting Toxicities for Bevacizumab With Radiation and Chemotherapy: Continued Experience of a Phase I Trial in Rectal Cancer Patients
|Journal of Clinical Oncology|2005|419
Autoimmune Pancreatitis: A Systemic Immune Complex Mediated Disease
|The American Journal of Surgical Pathology|2006|318